I will set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation.

Jim Banks · Indiana · Republican

policy impact 5.00 specificity 1.00 extraction confidence 98%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Occurrences

Set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation.

Banks will impose production limits on compounded drug copies to prevent abuse and legal challenges.

Senator Jim Banks Introduces SAFE Drugs Act to Crack Down on Risky and Fraudulent Weight Loss Drugs
primary · press_release · model gpt-4.1

does not, more than 20 times in a single month, compound any drug product that is essentially a copy of a commercially available drug product

The bill would prohibit 503A compounders from making an essentially copied drug product more than 20 times in a single month.

BILLS-119s3794is.pdf
primary · other · model gpt-5.4-mini

Evidence

unverified · Source version 5681 · locator unknown

Key provisions say the bill would "Set a clear monthly limit on how many 'essential copies' a 503A compounder may produce to ensure consistency and reduce litigation." The press release says Banks introduced the SAFE Drugs Act this week and that the bill would strengthen existing guardrails in the Food, Drug, and Cosmetic Act.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Banks introduced legislation containing the promised monthly-limit language, but this is only introduction, not enactment.

partial same_term A for effort

Senator Jim Banks Introduces SAFE Drugs Act to Crack Down on Risky and Fraudulent Weight Loss Drugs
primary · model gpt-5.4-mini · confidence 97%

unverified · Source version 769 · locator unknown

The legislation page lists "02-26-2026 | S.3794 | SAFE Drugs Act of 2026" with "Latest Action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions."

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The bill carrying the monthly-limit proposal was introduced and referred, but there is no later evidence of passage or enactment in the current record.

unresolved same_term A for effort

Legislation - Senator Jim Banks
primary · model gpt-5.4-mini · confidence 95%

unverified · Source version 61957 · locator unknown

<DELETED>SEC. 2. DEFINITIONS RELATING TO COMPOUNDING OF DRUG PRODUCTS.</DELETED> <DELETED> Section 503A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a(b)) is amended--</DELETED> <DELETED> (1) by amending paragraph (1)(D) to read as follows:</DELETED> <DELETED> ``(D) does not, more than 20 times in a single month, compound any drug product that is essentially a copy of a commercially available drug product.''; and</DELETED>

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The reported Senate version marks the original monthly-limit section and the specific 20-times-per-month essential-copy cap as deleted, showing the current reported vehicle no longer contains the promised limit.

never same_term A for effort

S. 3794 Reported in Senate (RS) - Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026
secondary · model gpt-5.5 · confidence 96%

unverified · Source version 61959 · locator unknown

S. 3794, SAFE Drugs Act of 2026 (Agreed to by Roll Call Vote, 17-5) S. 3794 Manager's Amendment (Agreed to by Voice Vote)

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The Senate HELP Committee advanced S. 3794 as amended, documenting serious legislative effort, but the committee action was not enactment of the promised monthly limit.

partial same_term A for effort

The Following Agenda to be Considered | Senate Committee on Health, Education, Labor and Pensions
secondary · model gpt-5.5 · confidence 93%

unverified · Source version 73914 · locator unknown

524 S. 3794 A bill to amend the July 27, 2026.--Senator Senators Banks Federal Food, Drug, and Cassidy, Committee on and Heinrich Cosmetic Act to further Health, Education, regulate compounding Labor, and Pensions, pharmacies and with an amendment in outsourcing facilities, the nature of a and for other purposes. substitute. (No written report.)

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The latest official Senate calendar located in the lookback window still lists S.3794 as a General Orders item reported with a substitute amendment, not as passed or enacted.

unresolved same_term A for effort

Senate Calendars for September 28, 2026 - 119th Congress, 2nd Session-GENERAL ORDERS
secondary · model gpt-5.5 · confidence 94%

unverified · Source version 86282 · locator unknown

524 S. 3794 A bill to amend the July 27, 2026.--Senator

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The latest Senate calendar found in the lookback window still lists S. 3794 on General Orders, with no passage or enactment shown.

unresolved same_term A for effort

Senate Calendars for October 6, 2026 - 119th Congress, 2nd Session-GENERAL ORDERS
secondary · model gpt-5.5 · confidence 95%

unverified · Source version 86284 · locator unknown

S. 3794.-- To amend the Federal Food, Drug, and Cosmetic Act to further regulate compounding pharmacies and outsourcing facilities, and for other purposes.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The House calendar history lists S. 3794 as a Senate bill with only referral and reported-amended history, not as passed by either chamber or enacted.

unresolved same_term A for effort

House Calendars for October 5, 2026 - 119th Congress, 2nd Session-HISTORY OF BILLS AND RESOLUTIONS - SENATE BILLS
secondary · model gpt-5.5 · confidence 94%

unverified · Source version 86286 · locator unknown

Last Action Date Listed July 27, 2026

Unverified model/legacy excerpt; not proof. AI summary (separate from source): GovInfo's bill detail page lists the latest action date as July 27, 2026, consistent with no later enactment found during the lookback refresh.

unresolved same_term A for effort

S. 3794 (RS) - Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026 - BILLS-119s3794rs | Related Documents | GovInfo
secondary · model gpt-5.5 · confidence 95%

unverified · Source version 61957 · locator unknown

<DELETED> ``(D) does not, more than 20 times in a single month, compound any drug product that is essentially a copy

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The reported Senate version marks the original 20-times-per-month essential-copy limit as deleted, showing the current reported vehicle no longer contains the promised monthly cap.

never same_term A for effort

S. 3794 Reported in Senate (RS) - Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026
secondary · model gpt-5.5 · confidence 97%

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): never. same_term A for effort

Banks introduced the SAFE Drugs Act of 2026 containing the promised monthly limit for 503A compounders, and the bill was referred to the Senate HELP Committee. The record shows introduction and referral only, with no evidence that the monthly limit was enacted or otherwise implemented. This is a serious legislative attempt during his federal Senate term, but it does not fulfill the promised outcome.

provider codex_cli · model gpt-5.5 · confidence 96%